MedDataX Logo

Lymphoma and T Helper 2 Cytokines Relationship With Prognostic Markers

NCT ID: NCT01639716

Last Updated: 2012-07-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

58 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-05-31

Study Completion Date

2012-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators hypothesized that Non Hodgkin lymphoma is using T helper 2 pathways. So that the investigators decided to study of cytokines related to T helper 2 pathways. It is well known that parasites and allergic situations also use T helper 2 pathways. Because that the investigators excluded the patients have parasites and allergic situations. All the patients were over 18. The investigators included the patients with non Hodgkin lymphoma which new diagnosed. It is observational study. The investigators took blood before chemotherapy and four months later. The investigators did not interfere with which chemotherapy will be given to patients. This decision was belong to hematologist or oncologist who will treat the patient.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lymphoma

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Survey, interleukin status

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lymphoma group

No interventions assigned to this group

healthy group

No interventions assigned to this group

IL-10 high

No interventions assigned to this group

IL-10 low

No interventions assigned to this group

IL-4 high

No interventions assigned to this group

IL-4 low

No interventions assigned to this group

lymphopenia

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* newly diagnosed non hodgkin lymphoma
* Diffuse large B cell lymphoma and T cell lymphoma patients

Exclusion Criteria

* under 18 age
* parasitosis
* allergic status
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Nil Guler

INDIV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nil Guler

Medical Doctor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nil Guler, MD

Role: PRINCIPAL_INVESTIGATOR

Nil Guler, MD

Role: PRINCIPAL_INVESTIGATOR

ONDOKUZ MAYİS UNİVERSİTY, SCHOOL OF MEDİCİNE

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ondokuz Mayis University Medical School

Samsun, Atakum, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.omu.edu.tr

OMU School of Medicine. Contact via e-mail.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NG6420

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

NG6420

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

NG63900

Identifier Type: -

Identifier Source: org_study_id